Skip to Content
Merck
  • Single-cell brain organoid screening identifies developmental defects in autism.

Single-cell brain organoid screening identifies developmental defects in autism.

Nature (2023-09-14)
Chong Li, Jonas Simon Fleck, Catarina Martins-Costa, Thomas R Burkard, Jan Themann, Marlene Stuempflen, Angela Maria Peer, Ábel Vertesy, Jamie B Littleboy, Christopher Esk, Ulrich Elling, Gregor Kasprian, Nina S Corsini, Barbara Treutlein, Juergen A Knoblich
ABSTRACT

The development of the human brain involves unique processes (not observed in many other species) that can contribute to neurodevelopmental disorders1-4. Cerebral organoids enable the study of neurodevelopmental disorders in a human context. We have developed the CRISPR-human organoids-single-cell RNA sequencing (CHOOSE) system, which uses verified pairs of guide RNAs, inducible CRISPR-Cas9-based genetic disruption and single-cell transcriptomics for pooled loss-of-function screening in mosaic organoids. Here we show that perturbation of 36 high-risk autism spectrum disorder genes related to transcriptional regulation uncovers their effects on cell fate determination. We find that dorsal intermediate progenitors, ventral progenitors and upper-layer excitatory neurons are among the most vulnerable cell types. We construct a developmental gene regulatory network of cerebral organoids from single-cell transcriptomes and chromatin modalities and identify autism spectrum disorder-associated and perturbation-enriched regulatory modules. Perturbing members of the BRG1/BRM-associated factor (BAF) chromatin remodelling complex leads to enrichment of ventral telencephalon progenitors. Specifically, mutating the BAF subunit ARID1B affects the fate transition of progenitors to oligodendrocyte and interneuron precursor cells, a phenotype that we confirmed in patient-specific induced pluripotent stem cell-derived organoids. Our study paves the way for high-throughput phenotypic characterization of disease susceptibility genes in organoid models with cell state, molecular pathway and gene regulatory network readouts.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-KMT2C antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody
Pricing and availability is not currently available.
Sigma-Aldrich
(Z)-4-Hydroxytamoxifen, ≥98% Z isomer
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
5 mg
1 Available to ship on 16 December 2024
Details...
€247.00
25 mg
1 Available to ship on 16 December 2024
Details...
€874.00